Skip to content
10-Q

Quarterly Report

PAVmed Inc. PAVM

0001641172-25-010433

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q1 2025 · Mar 31, 2025 $44.99M
Stockholders Equity Q1 2025 · Feb 14, 2025 $2.5M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$2.5M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.78M
Current Liabilities Q1 2025 · Dec 31, 2024 $35.45M
Total Liabilities Q1 2025 · Mar 31, 2025 $11.89M
Total Liabilities Q1 2025 · Dec 31, 2024 $37.69M
Current Assets Q1 2025 · Mar 31, 2025 $3.64M
Current Assets Q1 2025 · Dec 31, 2024 $2.16M
Total Assets Q1 2025 · Mar 31, 2025 $52.82M
Total Assets Q1 2025 · Dec 31, 2024 $30.66M
Cost Of Revenue Q1 2025 · Sep 10, 2024 $36K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.74M
Shares Diluted Q1 2025 · Mar 31, 2024 8.69M sh
Capex Q1 2025 · Mar 31, 2024 $42K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$13.11M
Eps Diluted Q1 2025 · Mar 31, 2024 −$2.62
Eps Basic Q1 2025 · Mar 31, 2024 −$2.62
Sga Expense Q1 2025 · Mar 31, 2024 $6.68M
Rd Expense Q1 2025 · Mar 31, 2024 $1.94M
Net Income Q1 2025 · Mar 31, 2024 −$15.21M
Operating Income Q1 2025 · Mar 31, 2024 −$14.04M
Revenue Q1 2025 · Mar 31, 2024 $1.01M